Imaging Tumor Hypoxia and Tumor Perfusion.
- Published in:
- Journal of Nuclear Medicine, 1993, v. 34, n. 6, p. 885
- By:
- Publication type:
- Article
Works matching AU McEwan, Alexander J. B.
Results: 17
1
2
Comparison of 30 mCi and 50 mCi I-131 doses for ablation of thyroid remnant in papillary thyroid cancer patients.
- Published in:
- Endocrine Research, 2028, v. 43, n. 1, p. 11, doi. 10.1080/07435800.2017.1346662
- By:
- Publication type:
- Article
3
Comparison of 30 mCi and 50 mCi I-131 doses for ablation of thyroid remnant in papillary thyroid cancer patients.
- Published in:
- Endocrine Research, 2018, v. 43, n. 1, p. 11, doi. 10.1080/07435800.2017.1346662
- By:
- Publication type:
- Article
4
Low but measurable stimulated serum thyroglobulin levels <2 µg/L frequently predict incomplete response in differentiated thyroid cancer patients.
- Published in:
- Endocrine Research, 2014, v. 39, n. 4, p. 157, doi. 10.3109/07435800.2013.865211
- By:
- Publication type:
- Article
5
Clinical Trial with Sodium <sup>99m</sup>Tc-Pertechnetate Produced by a Medium-Energy Cyclotron: Biodistribution and Safety Assessment in Patients with Abnormal Thyroid Function.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 5, p. 791, doi. 10.2967/jnumed.116.178509
- By:
- Publication type:
- Article
6
Site Qualification in Multicenter Clinical Trials.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 8, p. 30N
- By:
- Publication type:
- Article
7
Molecular Imaging: The Future of Modern Medicine.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 6, p. 16N
- By:
- Publication type:
- Article
8
Communication--A Process of Continuous Improvement.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 5, p. 25N
- By:
- Publication type:
- Article
9
Does Health Technology Assessment Put Patient Care at Risk?
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 12, p. 1939
- By:
- Publication type:
- Article
10
Hypoxia-Specific Tumor Imaging with <sup>18</sup>F-Fluoroazomycin Arabinoside.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 1, p. 106
- By:
- Publication type:
- Article
11
Radioisotope Therapy and Clinical Trial Design: The Need for Consensus and Innovation.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 1, p. 87
- By:
- Publication type:
- Article
12
Dosimetry Estimations for <sup>123</sup>I-IAZA in Healthy Volunteers.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 9, p. 1418
- By:
- Publication type:
- Article
13
Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 8, p. 1655, doi. 10.3390/pharmaceutics14081655
- By:
- Publication type:
- Article
14
Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [<sup>123</sup>I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress.
- Published in:
- Pharmaceutics, 2018, v. 10, n. 1, p. 25, doi. 10.3390/pharmaceutics10010025
- By:
- Publication type:
- Article
15
Rapid Standardized CT-Based Method to Determine Lean Body Mass SUV for PET--A Significant Improvement Over Prediction Equations.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.812777
- By:
- Publication type:
- Article
16
Initial results of hypoxia imaging using 1-α-D-(5-deoxy-5-[<sup>18</sup>F]-fluoroarabinofuranosyl)-2-nitroimidazole (<sup>18</sup>F-FAZA).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 10, p. 1565, doi. 10.1007/s00259-009-1154-5
- By:
- Publication type:
- Article
17
Marginal cost of operating a positron emission tomography center in a regulatory environment.
- Published in:
- International Journal of Technology Assessment in Health Care, 2005, v. 21, n. 4, p. 442, doi. 10.1017/S0266462305050610
- By:
- Publication type:
- Article